Clinical Trials Directory

Trials / Completed

CompletedNCT03811977

The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters

The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters: Randomised Double-Blind Placebo Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
VIST - Faculty of Applied Sciences · Academic / Other
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

The double-center, randomized, placebo-controlled, one-period effectiveness study will include 30 subjects (women, aged between 25 to 55 years, Fitzpatrick phototype II and III). Subjects will be divided in two groups, 15 in each. One group (test group) will receive investigational product - lutein syrup (4 mg/mL; daily dose 20 mg) and the other (placebo group) placebo syrup. Participants will test continuous administration of placebo or investigational product for 12 weeks in order to demonstrate and assess multiple-dose effects. The primary objective is to assess the photoprotective potential of the investigational product in relation to placebo product. The secondary objectives are to assess effects of investigational product on dermis density and skin viscoelasticity after 12 weeks of dietary supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLutein syrup12- week dietary supplementation with lutein syrup (20 mg lutein/day)
DIETARY_SUPPLEMENTPlacebo syrup12- week dietary supplementation with placebo syrup (0 mg lutein/day)

Timeline

Start date
2019-03-04
Primary completion
2019-07-02
Completion
2019-08-30
First posted
2019-01-22
Last updated
2019-09-03

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT03811977. Inclusion in this directory is not an endorsement.

The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters (NCT03811977) · Clinical Trials Directory